Asymchem Laboratories (Tianjin) Co., Ltd.

SZSE:002821.SZ

149 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q3
Revenue 1,427.2141,281.9021,358.7821,427.0631,761.5472,372.4762,249.0342,443.752,770.3252,979.5412,061.7091,715.8481,162.799982.998777.1891,066.844816.913790.436475.497717.5649.414616.576476.494629.915447.325393.982363.657527.095344.465261.375290.098317.391315.329283.794186.681310.716149.062
Cost of Revenue 774.588800.973790.599926.407759.0651,008.6291,160.3941,251.5021,475.2551,541.9481,128.892972.607639.607526.134444.047609.41423.229402.157248.704375.048355.898343.931265.706334.018238.6226.487182.569263.33158.021115.477149.903170.895125.828148.50688.688174.60968.16
Gross Profit 652.626480.929568.182500.6561,002.4821,363.8471,088.6411,192.2481,295.071,437.593932.817743.241523.192456.863333.142457.434393.684388.28226.793342.452293.516272.645210.788295.897208.724167.495181.087263.765186.444145.898140.194146.496189.501135.28897.993136.10780.902
Gross Profit Ratio 0.4570.3750.4180.3510.5690.5750.4840.4880.4670.4820.4520.4330.450.4650.4290.4290.4820.4910.4770.4770.4520.4420.4420.470.4670.4250.4980.50.5410.5580.4830.4620.6010.4770.5250.4380.543
Reseach & Development Expenses 155.451153.226169.442188.791189.644161.374162.097266.687178.88132.44130.884130.28193.30280.45483.44188.80461.36153.92454.84657.87356.24441.42936.97653.76546.68623.58231.144125.85529.62138.997070.48032.008065.0950
General & Administrative Expenses 0-52.135172.605-290.205450.361-54.572165.671-286.432413.672-54.775162.978-158.512277.201-64.00798.61-128.82180.038-22.03155.116-113.71167.908-22.92756.609-87.13667.998-46.38767.749-126.29965.504-37.22157.378-106.71847.742-24.33840.582-102.15138.747
Selling & Marketing Expenses 057.80144.62257.43556.95948.21533.81653.92444.930.82520.54135.45424.5420.42319.14118.45423.80621.82520.16827.90422.0821.12616.4231.3115.18615.41912.45417.46113.53613.3759.16214.27510.82810.4277.51911.0759.154
SG&A 253.353217.12215.698249.01507.319-6.357199.487-232.508458.572-23.951183.519-123.057301.741-43.584117.752-110.367103.844-0.20675.284-85.80789.988-1.80173.029-55.82683.184-30.96880.203-108.83879.04-23.84666.54-92.44358.57-13.9148.102-91.07647.901
Other Expenses -3.774-8.907-0.025-20.7182.848-4.064-8.148577.054-215.703227.9631.77716.491.6680.0580.138-0.07-0.009-1.6-0.8590.005-0.06-0.015-0.012-0.519-1.1910.3420.6042.632-0.049-3.0232.9314.1361.7563.2381.49113.862-20.598
Operating Expenses 412.578379.253385.141458.519478.596399.721353.436611.233421.749336.453316.18319.749229.288152.289179.42176.475157.903123.806117.002106.069129.72132.837108.361111.995129.4787.93471.70973.64272.32338.53368.03795.88661.0667.84246.94159.13250.503
Operating Income 240.048101.675183.04142.138559.7881,219.851709.949604.81,133.6291,422.253570.098419.796290.837316.576165.153239.184217.697240.664119.35211.209152.882156.677102.899187.4997.413107.87268.611157.6297.1994.65770.12164.579131.86976.16742.30878.17840.744
Operating Income Ratio 0.1680.0790.1350.030.3180.5140.3160.2470.4090.4770.2770.2450.250.3220.2130.2240.2660.3040.2510.2940.2350.2540.2160.2980.2180.2740.1890.2990.2820.3620.2420.2030.4180.2680.2270.2520.273
Total Other Income Expenses Net -10.018141.444111.94852.736-0.146-1.071-0.249-1.534-0.201-1.093-3.009-1.277-1.39912.0611.568-41.845-18.092-25.418.699-25.169-10.97416.8550.463.06916.96728.653-40.164-29.759-17.061-15.7620.89518.0395.18311.951-7.25315.066-10.253
Income Before Tax 230.029243.119294.98994.874559.6421,218.78709.7603.2661,133.4291,421.161567.089418.519292.505316.634165.291239.114217.689239.064118.49211.214152.822156.663102.888186.97196.222108.21469.215160.36497.0691.60373.05368.649133.62479.39743.79992.0420.146
Income Before Tax Ratio 0.1610.190.2170.0660.3180.5140.3160.2470.4090.4770.2750.2440.2520.3220.2130.2240.2660.3020.2490.2940.2350.2540.2160.2970.2150.2750.190.3040.2820.350.2520.2160.4240.280.2350.2960.135
Income Tax Expense 18.73925.10215.13418.99740.826164.67881.8129.572152.586180.46567.6944.10126.99241.63910.96123.25227.10931.48410.4623.86615.62519.40810.82426.724-9.78320.43716.79317.18119.8659.69715.2895.40222.68614.1577.6212.0663.916
Net Income 211.194217.161281.9758.705523.7371,056.023630.346580.698980.8421,240.696499.398374.421265.524274.997154.33215.866190.615207.58108.03187.348137.197137.25592.064167.397104.23193.17663.492140.52275.96375.71449.08964.10799.60756.18632.83571.20617.8
Net Income Ratio 0.1480.1690.2080.0410.2970.4450.280.2380.3540.4160.2420.2180.2280.280.1990.2020.2330.2630.2270.2610.2110.2230.1930.2660.2330.2360.1750.2670.2210.290.1690.2020.3160.1980.1760.2290.119
EPS 0.60.640.760.161.452.931.721.573.734.721.361.431.11.140.460.940.590.90.340.820.430.60.290.750.340.410.210.610.240.330.160.360.390.310.130.380.068
EPS Diluted 0.60.640.760.161.452.931.721.573.734.721.361.421.11.140.460.940.590.90.340.820.430.60.290.750.340.410.20.610.240.330.160.360.390.310.130.380.068
EBITDA 231.192228.839286.485165.681566.5771,214.836699.027589.171,081.6771,439.682580.632437.567309.383313.547160.954251.631217.863281.426103.074219.935165.376136.14107.537190.82984.02764.83104.94143.448114.2492.60172.15789.157125.31974.43454.583103.38528.321
EBITDA Ratio 0.1620.1790.2110.1160.3220.5120.3110.2410.390.4830.2820.2550.2660.3190.2070.2360.2670.3560.2170.3070.2550.2210.2260.3030.1880.1650.2890.2720.3320.3540.2490.2810.3970.2620.2920.3330.19